Medical Condition News

RSS

NCCN announces new guidelines for patients with pancreatic Cancer

The National Comprehensive Cancer Network (NCCN), with the support of the Pancreatic Cancer Action Network, announces the latest addition to the library of NCCN Guidelines for PatientsTM, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology.

30 Aug 2012

Noven submits LDMP NDA with FDA to treat menopausal vasomotor symptoms

Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has submitted to the U.S. Food & Drug Administration a New Drug Application (NDA) seeking approval to market low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms associated with menopause.

30 Aug 2012

Lilly decides to terminate pomaglumetad methionil Phase III trial on schizophrenia

Eli Lilly and Company announced today the decision to stop ongoing clinical studies investigating pomaglumetad methionil, also known as mGlu2/3, for the treatment of patients suffering from schizophrenia.

30 Aug 2012

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

30 Aug 2012

CNIO team generates transgenic mouse model for aplastic anaemia associated with short telomeres

Aplastic anaemia is characterised by a reduction in the number of the bone marrow cells that go on to form the different cell types present in blood (essentially red blood cells, white blood cells and platelets). In most cases, the causes of the disorder are hard to determine, but some patients have been found to have genetic alterations leading to a shortening of their telomeres (the end regions of chromosomes that protect and stabilise DNA).

30 Aug 2012

Elan commences ELND005 Phase 2 study in Bipolar I Disorder

Elan Corporation, plc today announced that it has commenced a Phase 2, placebo-controlled, safety and efficacy study of oral ELND005 as an adjunctive maintenance treatment in patients with Bipolar I Disorder (BPD 1) to delay the time to occurrence of mood episodes.

30 Aug 2012

Carnegie Hill Radiology in New York installs Aquilion PRIME 160 series from Toshiba

Patients with irregular heartbeats (arrhythmia) are difficult to image with CT. Addressing this challenge, Carnegie Hill Radiology in New York installed the Aquilion PRIME 160 series from Toshiba America Medical Systems, Inc., featuring SURECardio Prospective software that automatically adjusts for irregular heartbeats, providing quicker, more accurate exams.

30 Aug 2012

FDA grants orphan designation to Aerial BioPharma’s ARL-N05 for treatment of narcolepsy

Aerial BioPharma, a biopharmaceutical company focused on developing biologics and small molecules for conditions in the central nervous system, has received orphan drug designation for its narcolepsy drug in development.

30 Aug 2012

Jobless working-age people with diabetes less likely to adhere to their medications

If you're diabetic or prone to diabetes, having a steady job appears to be good for your health, and not just because of the insurance coverage.

30 Aug 2012

ALK signs agreement to supply PRE-PEN to HealthTrust member facilities

ALK is pleased to announce that it has signed an agreement with HealthTrust Purchasing Group, LP to supply PRE-PEN (benzylpenicilloyl polylysine injection USP) the only FDA approved skin test for the diagnosis of penicillin allergy, to HealthTrust member facilities, including 1,400 acute care facilities, 10,600 ambulatory surgery centers, physician practices and alternate care sites.

30 Aug 2012

Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals

Sleep disorders are a large area. We are focused on one particular type of sleep disturbance called “non-restorative” sleep. People with this problem do sleep, but they don’t wake up feeling refreshed or feeling that their sleep has had the restorative effects of healthy sleep.

29 Aug 2012

Study finds decline in 30-day mortality of acute myocardial infarction with improved treatment

Improved treatment after acute myocardial infarction and less severe patient profile have reduced 30-day mortality over the past 15 years, according to research presented at ESC Congress 2012.

29 Aug 2012

AstraZeneca’s ticagrelor receives Class I recommendation from ESC

AstraZeneca today announced that ticagrelor, an oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines on the Management of Acute Myocardial Infarction in Patients Presenting with Persistent ST-Segment Elevation (STEMI)" guidelines.

29 Aug 2012

Omitting aspirin leads to less bleedings but does not increase risk of stent thrombosis, MI

Lifelong anticoagulation is necessary for the prevention of stroke in patients with rhythm disturbances and with mechanical valves. Patients who have a coronary stent implanted also need the antiplatelet drugs aspirin and clopidogrel to prevent the rare but lethal complication of stent thrombosis.

29 Aug 2012

Study shows molecular mechanism behind type 3c pancreatic diabetes

Mice develop pancreatic diabetes (type 3c) when they lack certain genes in the E2F group, and to understand how this happens, Olatz Zenarruzabeitia has focussed on the molecular mechanism behind it.

29 Aug 2012

New method simplifies pharmaceutical production of proteins

Engineering researchers at the University of Arkansas have developed a method to simplify the pharmaceutical production of proteins used in drugs that treat a variety of diseases and health conditions, including diabetes, cancer, arthritis and macular degeneration.

29 Aug 2012

UMHS, MidMichigan Health announce plans to affiliate as clinical and business partners

MidMichigan Health and the University of Michigan Health System have announced plans to affiliate as clinical and business partners.

29 Aug 2012

Genetic investigation of tribes may explain why East Asians have lower skin cancer rates

Genetic investigation of a Malaysian tribe may tell scientists why East Asians have light skin but lower skin cancer rates than Europeans, according to a team of international researchers. Understanding the differences could lead to a better way to protect people from skin cancer.

29 Aug 2012

New treatment for severe dry eye is now available at U-M’s Kellogg

A new treatment available at the University of Michigan Kellogg Eye Center—prosthetic replacement of the ocular surface ecosystem or PROSE—provides relief to patients who suffer from severe dry eye, often the result of cancer or complex corneal disease.

29 Aug 2012

FISH assay identifies only few lung cancer patients who could benefit from crizotinib

Break apart a couple worm-like chromosomes and they may reconnect with mismatched tips and tails - such is the case of the EML4-ALK fusion gene that creates 2-7 percent of lung cancers. Almost exactly a year ago, the FDA approved the drug crizotinib to treat these ALK+ lung cancer patients, who were likely never smokers. Informed doctors use the test called a FISH assay to check for the EML4-ALK fusion gene, and then if the test is positive, ALK+ patients benefit greatly from crizotinib.

29 Aug 2012

Medical Condition News

NCCN announces new guidelines for patients with pancreatic Cancer

Noven submits LDMP NDA with FDA to treat menopausal vasomotor symptoms

Lilly decides to terminate pomaglumetad methionil Phase III trial on schizophrenia

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

CNIO team generates transgenic mouse model for aplastic anaemia associated with short telomeres

Elan commences ELND005 Phase 2 study in Bipolar I Disorder

Carnegie Hill Radiology in New York installs Aquilion PRIME 160 series from Toshiba

FDA grants orphan designation to Aerial BioPharma’s ARL-N05 for treatment of narcolepsy

Jobless working-age people with diabetes less likely to adhere to their medications

ALK signs agreement to supply PRE-PEN to HealthTrust member facilities

Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals

Study finds decline in 30-day mortality of acute myocardial infarction with improved treatment

AstraZeneca’s ticagrelor receives Class I recommendation from ESC

Omitting aspirin leads to less bleedings but does not increase risk of stent thrombosis, MI

Study shows molecular mechanism behind type 3c pancreatic diabetes

New method simplifies pharmaceutical production of proteins

UMHS, MidMichigan Health announce plans to affiliate as clinical and business partners

Genetic investigation of tribes may explain why East Asians have lower skin cancer rates

New treatment for severe dry eye is now available at U-M’s Kellogg

FISH assay identifies only few lung cancer patients who could benefit from crizotinib

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Latest News